FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 335:345-346 August 1, 1996 Number 5 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

The measurement of prostate-specific antigen (PSA) in serum is the most useful tool available today for the diagnosis of early, curable adenocarcinoma of the prostate.¹ This issue of the Journal contains the results of a well-conducted investigation of serum PSA concentrations in black men 40 to 79 years of age.² Previous investigations have examined serum PSA in white³ and Japanese⁴ men, but this study is the first to address the subject in blacks, the population with the highest prevalence of prostate cancer, the earliest age at its onset, and the greatest mortality rate from the disease. Like the investigators in . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Jacobson, M. W., Sawyer, R., Berman, J. J., Moore, G. W., Swee, D. E., Catalona, W. J., Moul, J. W., Morgan, T. O., Jacobson, S. J., Oesterling, J. E. (1997). Prostate-Specific Antigen in Black Men. NEJM 336: 133-136 [Full Text]